Global Asthma and COPD Drugs Market Size, Share, Analysis, Industry Report and Forecast 2020-2026
The global market for asthma and chronic obstructive pulmonary disease (COPD) drugs is estimated to have a significant CAGR during the forecast period. The market is mainly driven due to increasing prevalence of respiratory diseases such as asthma and COPD across the globe coupled with growing R&D for the development of new drugs. Asthma is one of the major respiratory diseases that has affected almost every major economy across the globe. During an asthma attack, the lining of the bronchial tubes swells, which results in narrowing of airways and reduced flow of air through lungs. According to the Global Asthma Report 2018, Asthma affects 339 million people across all regions. It is one of the major causes of death and disability as nearly 1,000 people lost their lives each day due to asthma. Moreover, it was estimated that 3.17 million mortalities were caused due to COPD in 2015, which is 5% of all the mortalities across the globe in 2016.Therefore significant number of asthma and COPD contribute in the market.
To Request a Sample of our Report on Global Asthma and
COPD Drugs Market: https://www.omrglobal.com/request-sample/asthma-and-copd-drugs-market
The global asthma and COPD drugs market is segmented based on
disease type and application. Based on the disease type, the market is further
classified into asthma and COPD. The asthma segment is projected to have
considerable share owing to the high demand of drug treatment in asthma coupled
with growing asthma across the globe. Based on the drug class, the global
asthma and COPD drugs market is further segmented into anti-inflammatory drugs,
combination drugs, monoclonal antibodies, bronchodilators.
A
full Report of Global Asthma and COPD Drugs Market is Available at: https://www.omrglobal.com/industry-reports/asthma-and-copd-drugs-market
Global Asthma
and COPD Drugs Market Segmentation
·
Asthma
·
COPD
By Drug class
·
Anti-inflammatory
Drugs
·
Combination
Drugs
·
Monoclonal
Antibodies
·
Bronchodilators
Regional
Analysis
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of The World
Company
Profiles
·
Amgen
Inc.
·
AptarGroup,
Inc.
·
AstraZeneca
PLC
·
Boehringer
Ingelheim International GmbH
·
Cipla
Ltd.
·
F.
Hoffmann-La Roche Ltd.
·
GlaxoSmithKline
PLC
·
Grifols,
S.A.
·
Glenmark
Pharmaceuticals
·
Merck
& Co., Inc.
·
MediciNova,
Inc.
·
Mylan
N.V.
·
Novartis
AG
·
Pfizer
Inc.
·
Respiratorius
AB
·
Teva
Pharmaceutical Industries Ltd.
·
Vectura
Group plc
·
Verona
Pharma plc
Reasons to Buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data, Request for
Report Customization @ https://www.omrglobal.com/report-customization/asthma-and-copd-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
For
More Information, Visit Orion Market Research
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment